Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

BACKGROUND Results of array studies have suggested abnormalities in expression of lipid and myelin-related genes in schizophrenia. Here, we investigated oligodendrocyte-specific and myelination-associated gene expression in schizophrenia and bipolar affective disorder. METHODS We used samples from the Stanley brain collection, consisting of 15 schizophrenia, 15 bipolar affective disorder, and 15 control brains. Indexing-based differential display PCR was done to screen for differences in gene expression in schizophrenia patients versus controls. Results were cross-validated with quantitative PCR, which was also used to investigate expression profiles of 16 other oligodendrocyte and myelin genes in schizophrenia and bipolar disorder. These genes were further investigated with an ongoing microarray analysis. FINDINGS Results of differential display and quantitative PCR analysis showed a reduction of key oligodendrocyte-related and myelin-related genes in schizophrenia and bipolar patients; expression changes for both disorders showed a high degree of overlap. Microarray results of the same genes investigated by quantitative PCR correlated well overall. INTERPRETATION Schizophrenia and bipolar brains showed downregulation of key oligodendrocyte and myelination genes, including transcription factors that regulate these genes, compared with control brains. These results lend support to and extend observations from other microarray investigations. Our study also showed similar expression changes to the schizophrenia group in bipolar brains, which thus lends support to the notion that the disorders share common causative and pathophysiological pathways.

[1]  S. Malcolm,et al.  The proteolipid protein gene and myelin disorders in man and animal models , 2000 .

[2]  M. Starkey,et al.  Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study , 2002, The Lancet.

[3]  Erik A Sistermans,et al.  Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. , 2002, Brain : a journal of neurology.

[4]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[5]  J. Trent,et al.  Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays , 1999 .

[6]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M S Buchsbaum,et al.  MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia , 1998, Neuroreport.

[8]  R. Harris,et al.  Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics , 2002, Journal of neurochemistry.

[9]  G J Barker,et al.  In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[10]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[11]  R. Yolken,et al.  The Stanley Foundation brain collection and Neuropathology Consortium , 2000, Schizophrenia Research.

[12]  A. Czernik,et al.  Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique , 2001, Neuroscience Letters.

[13]  N. Baumann,et al.  Biology of oligodendrocyte and myelin in the mammalian central nervous system. , 2001, Physiological reviews.

[14]  A. D. de Crespigny,et al.  Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. , 1999, Archives of general psychiatry.

[15]  B. Popko,et al.  Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions , 2002, The Journal of cell biology.

[16]  D. Rowitch,et al.  Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Wechser,et al.  Human disease characterization: real-time quantitative PCR analysis of gene expression. , 2001, Drug discovery today.

[18]  M. Wegner,et al.  Sox10, a Novel Transcriptional Modulator in Glial Cells , 1998, The Journal of Neuroscience.

[19]  Eric P. Hoffman,et al.  Gene Expression Profiling in Postmortem Rett Syndrome Brain: Differential Gene Expression and Patient Classification , 2001, Neurobiology of Disease.

[20]  Alessandro Bertolino,et al.  The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia , 2001, Biological Psychiatry.

[21]  C. Mayanil,et al.  Microarray Analysis Detects Novel Pax3 Downstream Target Genes* 210 , 2001, The Journal of Biological Chemistry.

[22]  L. Lindholm.  Major benefits from cholesterol-lowering in patients with diabetes , 2003, The Lancet.

[23]  Yi Guan,et al.  Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.

[24]  R. Collins,et al.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.

[25]  C. Dion,et al.  6p24-22 region and major psychoses in the Eastern Quebec population. Le Groupe IREP. , 1997, American journal of medical genetics.

[26]  A. Farmer,et al.  Clinical genetics as clues to the "real" genetics of schizophrenia (a decade of modest gains while playing for time). , 1987, Schizophrenia bulletin.

[27]  Patrick R. Hof,et al.  Molecular and Cellular Evidence for an Oligodendrocyte Abnormality in Schizophrenia , 2002, Neurochemical Research.

[28]  D. Horrobin,et al.  New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[29]  J. Connor,et al.  Iron acquisition and expression of iron regulatory proteins in the developing brain: manipulation by ethanol exposure, iron deprivation and cellular dysfunction. , 1994, Developmental neuroscience.

[30]  S. Sealfon,et al.  Gonadotropin-releasing Hormone Receptor-coupled Gene Network Organization * , 2001 .

[31]  David J. Anderson,et al.  The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification , 2002, Cell.

[32]  F. Benes,et al.  Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. , 1986, Archives of general psychiatry.

[33]  K Kosaka,et al.  Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. , 2001, Biochemical and biophysical research communications.

[34]  F. Middleton,et al.  Gene Expression Profiling with DNA Microarrays: Advancing Our Understanding of Psychiatric Disorders , 2002, Neurochemical Research.

[35]  E. Topol,et al.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials , 2003, The Lancet.

[36]  N. Uranova,et al.  Electron microscopy of oligodendroglia in severe mental illness , 2001, Brain Research Bulletin.

[37]  Alessandro Bertolino,et al.  Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study , 1998, Biological Psychiatry.

[38]  D. Rowitch,et al.  Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives , 2001, International Journal of Developmental Neuroscience.

[39]  M. Wegner,et al.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. , 2002, Genes & development.

[40]  Peter B. Jones,et al.  Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Connor,et al.  Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. , 1997, The Journal of nutrition.